Invention Grant
- Patent Title: Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same
-
Application No.: US15833520Application Date: 2017-12-06
-
Publication No.: US10765726B2Publication Date: 2020-09-08
- Inventor: Uma Sinha , Genmin Lu , Athiwat Hutchaleelaha , Stanley J. Hollenbach
- Applicant: Portola Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Portola Pharmaceuticals, Inc.
- Current Assignee: Portola Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: A61K38/36
- IPC: A61K38/36 ; A61K38/48 ; C12N9/64 ; A61K9/00
Abstract:
The present invention relates unit dose formulations of antidotes to anticoagulants targeting factor Xa. Disclosed herein are methods of stopping or preventing bleeding in a patient that is currently undergoing anticoagulant therapy with a factor Xa inhibitor.
Public/Granted literature
- US20180236049A1 UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME Public/Granted day:2018-08-23
Information query
IPC分类:
